Clinical Trial
Accepted on 01 Apr 2025
Exploratory Analysis of Bezisterim Treatment Associated With Decreased Biological Age Acceleration, and Improved Clinical Measure and Biomarker Changes in Mild-to-Moderate Probable Alzheimer's Disease
in Neuropharmacology